These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
317 related articles for article (PubMed ID: 35255755)
21. Clinical Simulation in the Regulation of Software as a Medical Device: An eDelphi Study. O'Driscoll F; O'Brien N; Guo C; Prime M; Darzi A; Ghafur S JMIR Form Res; 2024 Jun; 8():e56241. PubMed ID: 38917454 [TBL] [Abstract][Full Text] [Related]
22. Artificial Intelligence and Machine Learning Applied at the Point of Care. Angehrn Z; Haldna L; Zandvliet AS; Gil Berglund E; Zeeuw J; Amzal B; Cheung SYA; Polasek TM; Pfister M; Kerbusch T; Heckman NM Front Pharmacol; 2020; 11():759. PubMed ID: 32625083 [TBL] [Abstract][Full Text] [Related]
23. Technology-Enabled, Evidence-Driven, and Patient-Centered: The Way Forward for Regulating Software as a Medical Device. Carolan JE; McGonigle J; Dennis A; Lorgelly P; Banerjee A JMIR Med Inform; 2022 Jan; 10(1):e34038. PubMed ID: 35084352 [TBL] [Abstract][Full Text] [Related]
24. Industry ties and evidence in public comments on the FDA framework for modifications to artificial intelligence/machine learning-based medical devices: a cross sectional study. Smith JA; Abhari RE; Hussain Z; Heneghan C; Collins GS; Carr AJ BMJ Open; 2020 Oct; 10(10):e039969. PubMed ID: 33055121 [TBL] [Abstract][Full Text] [Related]
25. Tracking the Presence of Software as a Medical Device in US Food and Drug Administration Databases: Retrospective Data Analysis. Ceross A; Bergmann J JMIR Biomed Eng; 2021 Nov; 6(4):e20652. PubMed ID: 38907384 [TBL] [Abstract][Full Text] [Related]
26. Artificial intelligence (AI) impacting diagnosis of glaucoma and understanding the regulatory aspects of AI-based software as medical device. Prabhakar B; Singh RK; Yadav KS Comput Med Imaging Graph; 2021 Jan; 87():101818. PubMed ID: 33307283 [TBL] [Abstract][Full Text] [Related]
27. The current status and future of FDA-approved artificial intelligence tools in chest radiology in the United States. Milam ME; Koo CW Clin Radiol; 2023 Feb; 78(2):115-122. PubMed ID: 36180271 [TBL] [Abstract][Full Text] [Related]
28. Diabetes Technology Society Report on the FDA Digital Health Software Precertification Program Meeting. King F; Klonoff DC; Ahn D; Adi S; Berg EG; Bian J; Chen K; Drincic A; Heyl M; Magee M; Mulvaney S; Pavlovic Y; Prahalad P; Ryan M; Sabharwal A; Shah S; Spanakis E; Thompson BM; Thompson M; Wang J J Diabetes Sci Technol; 2019 Jan; 13(1):128-139. PubMed ID: 30394807 [TBL] [Abstract][Full Text] [Related]
29. Marketing and US Food and Drug Administration Clearance of Artificial Intelligence and Machine Learning Enabled Software in and as Medical Devices: A Systematic Review. Clark P; Kim J; Aphinyanaphongs Y JAMA Netw Open; 2023 Jul; 6(7):e2321792. PubMed ID: 37405771 [TBL] [Abstract][Full Text] [Related]
30. Breaking down the silos of artificial intelligence in surgery: glossary of terms. Moglia A; Georgiou K; Morelli L; Toutouzas K; Satava RM; Cuschieri A Surg Endosc; 2022 Nov; 36(11):7986-7997. PubMed ID: 35729406 [TBL] [Abstract][Full Text] [Related]
31. Collection and Analysis of Adherence Information for Software as a Medical Device Clinical Trials: Systematic Review. Grayek E; Krishnamurti T; Hu L; Babich O; Warren K; Fischhoff B JMIR Mhealth Uhealth; 2023 Nov; 11():e46237. PubMed ID: 37966871 [TBL] [Abstract][Full Text] [Related]
32. Expedited Programs for Serious Conditions: An Update on Breakthrough Therapy Designation. Kwok M; Foster T; Steinberg M Clin Ther; 2015 Sep; 37(9):2104-20. PubMed ID: 26297571 [TBL] [Abstract][Full Text] [Related]
33. Access and reimbursement pathways for digital health solutions and Mantovani A; Leopaldi C; Nighswander CM; Di Bidino R Front Med Technol; 2023; 5():1101476. PubMed ID: 36891483 [TBL] [Abstract][Full Text] [Related]
34. Digital technologies to unlock safe and sustainable opportunities for medical device and healthcare sectors with a focus on the combined use of digital twin and extended reality applications: A review. Rowan NJ Sci Total Environ; 2024 May; 926():171672. PubMed ID: 38485014 [TBL] [Abstract][Full Text] [Related]
35. Regulatory Frameworks for AI-Enabled Medical Device Software in China: Comparative Analysis and Review of Implications for Global Manufacturer. Han Y; Ceross A; Bergmann J JMIR AI; 2024 Jul; 3():e46871. PubMed ID: 39073860 [TBL] [Abstract][Full Text] [Related]
36. The future of Cochrane Neonatal. Soll RF; Ovelman C; McGuire W Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834 [TBL] [Abstract][Full Text] [Related]
37. Examining labelling guidelines for AI-based software as a medical device: A review and analysis of dermatology mobile applications in Australia. Oloruntoba A; Ingvar Å; Sashindranath M; Anthony O; Abbott L; Guitera P; Caccetta T; Janda M; Soyer HP; Mar V Australas J Dermatol; 2024 Aug; 65(5):409-422. PubMed ID: 38693690 [TBL] [Abstract][Full Text] [Related]
38. Implementing the human right to science in the regulatory governance of artificial intelligence in healthcare. Ho CWL J Law Biosci; 2023; 10(2):lsad026. PubMed ID: 37854168 [TBL] [Abstract][Full Text] [Related]
39. Evaluation of Mobile Health Applications: Is Regulatory Policy Up to the Challenge? Moshi MR; Parsons J; Tooher R; Merlin T Int J Technol Assess Health Care; 2019; 35(4):351-360. PubMed ID: 31307566 [TBL] [Abstract][Full Text] [Related]
40. The regulatory environment for artificial intelligence-enabled devices in the United States. Liang NL; Chung TK; Vorp DA Semin Vasc Surg; 2023 Sep; 36(3):435-439. PubMed ID: 37863617 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]